Researchers have reported that there is an association between BMI and eGFR. AS BMI increases chronic kidney disease prevalence increases in adults.

Purpose: the aim of this study is to analyze the relationship between eGFR vs. BMI and age for overweight and obese boys and girls visiting a pediatric clinic in South Texas.

Methods: to calculate eGFR the “Bedside Schwartz” formula: eGFR = 0.413 x (height/SCr) height expressed in centimeters was used to estimate kidney function for 583 girls and 650 boys visiting a pediatric clinic from 2001 to 2017. The children were classified as overweight and obese according with CDC BMI percentiles. Age in years were classified as follows. 1-4.9; 5-7.9; 8-10.9; 11-12.9; 13-15.9 and 16+ years. A general linear model: GFR = BMI + Age + Age*Age was used to analyze the data. IRB approval #2016-01-31 was obtained from the TAMIU IRB.

Results: girls: BMI levels were not significantly different. Age was significantly different (df=5, F=11.64, p<0.05), the interaction was not significant. The eGFR means by age were as follows: overweight: 128.19; 138.83; 136.73; 133.69; 120.11; 107.21. Age groups 5 and 6 were different from groups 1, 2, 3 and 4 (p<0.05). Obese: 127.41; 131.71; 130.58; 135.55; 121.00; 112.35. Age groups 5 and 6 were different from groups 1, 2, 3 and 4 (p<0.05), Graph 1. Boys: BMI levels were not significantly different. Age levels were significantly different (df=5, F=20.96; p<0.05), the interaction was not significant. The eGFR means by age were as follows: overweight: 133.84; 134.61; 136.91; 127.91; 120.51; 98.52. Age groups 5 and 6 were different from groups 1, 2, 3, and 4 (p<0.05). Obese: 126.74; 135.12; 140.23; 137.44; 117.64; 96.58 (p<0.05), Graph 2.

Conclusion: The results support that eGFR decreases as age increases for overweight and obese children from age 1 to age 16+. Therefore we can hypothesize that there is a relationship between kidney function and children overweight and obesity as age increases for the population of boys and girls studied.

Disclosure

F.G. Quintana: None. H. Wang: None. F.J. Cervantes-Gonzalez: None. M.A. Perez: None.

© 2018 by the American Diabetes Association.
2018
Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.